Back to Journals » Clinical Ophthalmology » Volume 3

Peripheral T-cell lymphoma of the eyelid

Authors Ishikawa M, Watabe H, Hayakawa M, Yoshitomi T

Published 23 September 2009 Volume 2009:3 Pages 527—529

DOI https://doi.org/10.2147/OPTH.S7717

Review by Single anonymous peer review

Peer reviewer comments 2



Makoto Ishikawa, Hiroshi Watabe, Masahiro Hayakawa, Takeshi Yoshitomi

Department of Ophthalmology, Akita University Faculty of Medicine, Akita, Japan

Purpose: To report a case of a 25-year-old woman with previously treated peripheral T-cell lymphoma (PTCL) presenting with a recurrent lower eyelid lesion.

Patients and method: Case report.

Results: A 25-year-old young woman with previously treated PTCL noted an induration in the skin of her left lower eyelid. Upon diagnosis of a chalazion, antibiotic eye drops and ointments as well as steroid eye drops were administered. However, the condition worsened rapidly and swelling of the lower eyelid became remarkable. An excisional biopsy revealed that the palpebral lesion was diagnosed as recurrence of PTCL. Electron irradiation was applied as a radical treatment, and the prognosis was satisfactory without recurrence at 10 months after the last irradiation.

Conclusions: Although lymphoma isolated to the ocular adnexa is rare, it should always be included in the differential diagnosis of any patient presenting with progressive swelling of the eyelid or ocular region.

Keywords: peripheral T-cell lymphoma, chalazion, eyelid

Creative Commons License © 2009 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.